Loading clinical trials...
Loading clinical trials...
Comparison of Blended Care Outpatient Neurorehabilitation With Traditional Outpatient Neurorehabilitation, a Crossover Pilot Study
What is this study about? Outpatient neurorehabilitation (therapy after leaving the hospital) is an important follow-up treatment for people who have had a stroke, brain bleeding, or serious head injury. It helps improve problems with movement, speech, memory, or daily activities. At the same time, there are not enough healthcare professionals, and healthcare costs are rising. Because of this, we need new and more efficient ways to provide therapy. One possible solution is telerehabilitation. This means patients do part of their therapy at home using video calls and apps. Early studies show that this can work well. However, in Switzerland it is still rarely used. One reason is that digital therapies are often not paid for, and there is still limited scientific proof of how effective they are. In this study, we want to find out how well a combination of traditional in-person therapy and digital therapy at home works. The goal is to make treatment more modern, effective, and affordable - benefiting patients, therapists, and the healthcare system. How is the study organized? Participants in the study are randomly divided into two groups. Group 1: First, they do three weeks of combined therapy: 1. therapy day per week at the hospital. 2. therapy days per week at home via Microsoft Teams video calls. On home days, they also complete exercises using apps provided by their therapists. After that, they do three weeks of therapy fully at the hospital (3 days per week). Group 2: First, they do three weeks of therapy at the hospital (3 days per week). After that, they do three weeks of combined therapy (hospital + home video therapy). Both groups receive the same types of therapy, just in a different order. This is called a crossover design. Because this is one of the first studies of its kind, we are starting with a small number of participants. This is called a pilot study.
During the preparation phase and at different points during the study, you will complete several tests and questionnaires. These take about 30-60 minutes each. These tests help us: Check whether you are physically stable and safe enough to take part in the therapy sessions. See how your physical and thinking abilities change over time. During the appointments, you will do exercises from: Physiotherapy Occupational therapy And, if needed, speech therapy and language therapy Each therapy session lasts 30-45 minutes. The exercises are a mix of: Paper-based exercises Conversations and guided exercises with your therapists Exercises using apps that you download to your phone or tablet during the preparation phase (you will receive instructions on how to use them) Benefits and Risks Taking part in this study does not provide a direct personal benefit to you. However, if this system proves to be successful, future patients may benefit from therapy that can be done from home. There is a risk that you may not do the exercises at home with the same intensity as in the therapy clinic. However, since you will stay in regular contact with your therapists at home, we expect that this risk will have only a small effect on how well the therapy works. Another possible risk is that, without a therapist physically present, you may lose your balance more easily at home, which could lead to a fall and injury. Before the study begins, we will carry out several tests to make sure you are able to safely participate in the different therapies. This helps reduce the risk that you cannot perform the exercises properly at home or that you get injured from a fall. Funding and Costs This study is organized and fully funded by Luzerner Kantonsspital. The researchers involved do not receive any direct financial benefit from conducting this study. You will not receive any payment or other compensation for participating. There will be no additional costs for you or for your health insurance if you take part in this study.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Start Date
March 1, 2026
Primary Completion Date
March 1, 2029
Completion Date
June 1, 2029
Last Updated
March 9, 2026
30
ESTIMATED participants
Blended care outpatient neurorehabilitation
OTHER
Lead Sponsor
Luzerner Kantonsspital
NCT05093673
NCT07371455
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06258538